NextCure Competitors and Similar CompaniesClear all
Ayala Pharmaceuticals's competitors and similar companies include Arvinas.
 Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. |  Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Wilmington, US HQ Rehovot, IL Wilmington, US | Locations New Haven, US HQ |
Employees | Employees 29 | Employees 13329% increase |
Valuation ($) | Valuation ($) 7.4 m | Valuation ($) 1.9 b |
Financial | ||
Revenue (est.) | Revenue (est.) $692k (FY, 2022) | Revenue (est.) $262.6m (FY, 2025) |
Net income | Net income ($38m) (FY, 2022) | Net income ($80.8m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 47m | Total funding raised $ 111.6m |
For sources of this data, please see the company profile
View Company Profiles
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View company